Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.

Theralase Technologies Inc. V.TLT

Alternate Symbol(s):  TLTFF

Theralase Technologies Inc. is a Canada-based clinical-stage pharmaceutical company. The Company is engaged in the research and development of light activated compounds and their associated drug formulations. The Company operates through two divisions: Anti-Cancer Therapy (ACT) and Cool Laser Therapy (CLT). The Anti-Cancer Therapy division develops patented, and patent pending drugs, called Photo Dynamic Compounds (PDCs) and activates them with patent pending laser technology to destroy specifically targeted cancers, bacteria and viruses. The CLT division is responsible for the Company’s medical laser business. The Cool Laser Therapy division designs, develops, manufactures and markets super-pulsed laser technology indicated for the healing of chronic knee pain. The technology has been used off-label for healing numerous nerve, muscle and joint conditions. The Company develops products both internally and using the assistance of specialist external resources.


TSXV:TLT - Post by User

Comment by N0taP00pon Aug 26, 2024 3:30pm
81 Views
Post# 36196537

RE:RE:266% increase...

RE:RE:266% increase...@Mikee3003:  I think the Kool-Aid is almost as potent as Ruvidar. 
Mikee3003 wrote: "OnceTLT-Ruvidar has been approved by the FDA, TLT will push forward with Metformin+Rutherrin to be part the solution for this FDA new big problem, as Metformin+Rutherrin has the potential to easily treat any cancer anywhere in the body."

"All the above is one more reason why the FDA has no choice but to give TLT-Ruvidar pre-BTD and BTD approval, before this new problem become apocaliptic."

The above statements are just absurd! Only the Kool-aid gang would think otherwise. I have worked in risk management all my life and if you think there is no risk with TLT you are very mistaken....and the market obviously agrees...hence the share price. Go ahead and Google some other medical conditions that Metformin+Ruvidar are going to cure......lol!





<< Previous
Bullboard Posts
Next >>